All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - PRO.

3 September 2019 (11:45 - 12:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail

Aspirin is out for primary prevention of cardiovascular disease - PRO.

Professor J. Armitage (Oxford, GB)

Presentation thumbnail

Aspirin is out for primary prevention of cardiovascular disease - CON.

Professor C. Patrono (Rome, IT)

Presentation thumbnail

Aspirin is out for primary prevention of cardiovascular disease - Discussion.

Presentation thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Doctor T. Cuisset (Marseille, FR)

Presentation thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - Discussion.

Access the full session

Session thumbnail

Controversies in antithrombotic treatment for primary and secondary prevention

The Event

ESC Congress 2019

3 September 2019 11:45 CET

You may be interested in

Congress Session

Challenges in hypertension management

Congress Presentation

Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension

Congress Session

Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources